Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This news is as significant to me as the allowance for including patients with less serious vision problem (20/100) in the ongoing trials. Since this trial is closely watched and scrutinized, this (new trial using our cells) says volumes for the progress for these ongoing trials for AMD and SMD. Safety was the primary observance for phase 1, and now its a almost certain that this has been achieved as we are allowing less severe patients involved in the present trial, ALONG with FDA allowance to start a NEW trial with a lesser severe desease (imo). It also makes one believe that efficacy is being seen as to compassionately help patients in earlier stages of the desease to halt the progression EARLIER of the sight deterioration. We have seen this in other drug trials to speed up the approval process when efficacy is being witnessed. All just IMO.
Some posters are not here to analyze the why's or anylyze anything for that matter. I think we ALL know why they are here everyday, negatively commenting on a stock they don't own.
The SCIENCE, THE SCIENCE, THE SCIENCE. That is the three things that keep me here in this stock. My view of management and leadership is not overly positve, but if I had control of this potential volcano, I would not relinquish the reins just yet either. That's why a partnership IMO would be welcome news. Guidence of knowledge in how to bring this powerful science to commercialization would subside the uncertainty of managements capabilities. But first things first: NEED FDA APPROVAL!!
>>Post the truth...<<
I have! --- what I believe is the personal motives of such posters.
My post was to educate other readers of this board that due to a personal prediction of a future declining price of this stock by yourself and others, that listening to such "personal" predictions and attempts for encouraging others to sell, that if they did sell, they missed out on the rise of the price to the high nines. Therefore my advice was NOT to listen to such posters who IMO have PERSONAL financial agendas while posting on this board. Believe me, I feel that NO ONE comes to post negatives on these boards JUST to save us strangers from ourselves. Have a good day all!
I can't remember, if someone can help me out, I would be very grateful. Who was the poster that said this price was going down to the fours as it was trading in the fives, when in fact it almost doubled to the upper nines. OOPS, they missed that one but they still continue to educate us on where they see the price is headed. Ok! I'll believe you!!
IMO, this price will hover in the .08 area until all free shares given in the settlement are in the float and trading. When that many free shares are in the hands of power, the price can easily be controlled by those with personal agendas.
>>because the price will come down as soon as camofi is done unloading<<
I could not disagree with this statement more. The reasons being that this stock is now trading off the highs of .20s is for a few reasons, one of which and probabaly the most important reason being that Wall Street KNEW that these free shares were going to enter the market trading (float) at a DISCOUNT from the current price. This was known when the price of this stock was MUCH higher than it is now -- thus the downside in price from the high of .20. This news (lawsuit) IMO is, and HAS BEEN, built into the price of the stock as of today. Make no mistake that the market IS a manipulative venue and I can't totally dismiss that the price is now may being held up at its current price for more sellers to move their shares, but after the selling is DONE I see no other reason (barring bad trial news) that the price will sustantially continue to decline. This (GIFT of free shares) IMO IS the main reson we are sitting way off our highs. One less negative dismissed (lawsuit) weighing on the price. The SEC, I see as a minor matter, compared to millions of share out there waiting to be sold! I have seen this before in other stocks and until free shares are ALL in the float, the weight is heavy on the stock price. Easy to manipulate the price when you control that many shares! When this is all said and done, IMO I expect the stock price to react positively.
>>I would have loved to have bought some of this back at .053 in
December 31 2012 but, I saw this from their Q10-3
ACTC IS A MONEY PIT/TRAP IMO.<<
Wasn't that about the time that one negative poster declared that the stock price was headed to the 4s, but then went into the 09s and now is in the .08s. --- hmmm, who was that again?
Please Crawford, we as investors, do not want to read about the positve developements and earth shattering potential of this company. We do not want to think about the dynamic news media blitz if/when trials are successful. We would much rather read posts from posters who do not own shares but feel compelled and determined to help us see the wrong we have done by investing in this potentially explosive company. Personally, I would much rather believe someone with no financial investment in this stock, sputing negatives about this company here all day, eveyday. They must be "saints" since they are here and so concerned for our personal financial well being so as to help us strangers from serious demise. Bless their souls. These truly are "heroes". Nobody would spend this much of their time on a message board if they were not TRULY interested in helping out us sorry unknowledgeable, bound to fail, investors. --- Yeah, that's the ticket!
I also remembering one poster say that this was going to visit the 4s. Of course, that did not happen but instead went from fives to nines.
This is probably the most insightful post of all time!!
Someone wanted to bring the price down?
And the price move upwards will be seen prior to dismissal news. ie. people in the know
I seem to recall that one negative poster here commented that, when the price was in the .05s, that it would see the .04s. This never happened but went up to the recent .09s. Gee for the life of me, I can't recall who this was. --- hmmm, maybe someone could help me remember who this poster was.
We can get the products in non english speaking European countries, but can't seem to get them on shelves in our neighbors to the north or our founding fathers country (UK). Unbelievable!
How's that ACTC short position treating you today. OUCH!
If anyone misses ddls, go over to the BIEL board on IHUB, you can find him there doing the same as he does/did here.
Yes, I'ld like to know why. Please enlighten us.
That is a standard disclosure statement used by most start up companies with no annual revenues to fund ongoing trials and business operations. Nice try, though.
Sorry threepointer, my post was mot meant to be a reply to your post. I should of hit "new post" (not reply).
>>A deliberate misspelling<< -- YEAH right! I believe you!
>>20 sense<< Really!!
Todays action and volume increase is, IMO, end of year tax selling. We will probably see similar action tomorrow. Just a personal hunch,but I will be adding on any price decrease tomorrow. Best of luck to all.
Speaking of "selling off the shelves in Canada, what in the world ever happened to that and the Greenwood Group? It is failures and/or unsuccessful launches (lies?)as this, that we were informed of by our "great" CEO, that have deteriorated stockholder's confidence along with the stock price. Until one of their so called projections and "news alerts" actually materializes, will anyone, (stockholder or wall street) take this BOZO CEO or companny seriously. Excuse me if I am NOT getting excited over this latest launching of products in Spain - been there, done that. Disclosure: frustrated shareholder for years.
Volume is better, but the bid needs to increase to get excited about this.
Who are you entertaining? Yourself? Thanks for coming clean with your reasons for posting on this board. Now any future readings of your post will be taken with that (your entertainment) in mind.
After reading, it sounds like this is where any FDA decision challenges go to be reviewed by a "higher court" so to speak. If petitioned company believes that so called shady decision making exists within the FDA this seems to be the organization that reviews such allegations and overseas the workings of the FDA. Being a government organization itself, I don't find it too promising that a unbiased decision will be made. Seems to be similar to an appeallate court trying to come down on one of the district judges -- doesn't happen often. After reading, this is NOT the only function of this organization, so there IS "hope" that in some other area of investigation our appeal will be successful. Always fun trying to deal with "unbiased" government organizations.
Not me. I will not sell, just add to my total. If the MMs want to bring this down, I will look at it as a buying opportunity to ADD more. Don't like trying to time the market.
Potential projected reverse split along with feared increased dilution from court litigation cases are serving as a "weight" on share price at this time. IMO investors are trying to time their entry or re-entry to this investment as to get the lowest pice of purchase. I myself am holding my shares but will add to them when I feel this "weight" is lightening. Hard to predict as institutional investing controls the market.
>>IMO, the classification of SWD devices should be based on power levels.<<
Excactly!! If the "all knowing" FDA cannot and will not realize this, then they ARE what we suspect them to be: clueless, self serving and big pharma's puppets. If and when approved, all it takes is conditional "warnings" for matters of concern: where and where not to place the patch - who should and should not use the patch etc. etc. Read any label on most medications taken orally. Side affects seem more serious than the original ailment. Still they are available with warnigs and are required to list possible problems resulting from use. Why in the world would this not be the same for this product.
I agree wholeheartedly!
Somebody liked what they heard yesterday. Nice change from when these conferences did nothing to help the share price.
I'm sorry Color, I don't understand. Andy said there have been NO denials, but we have recieved a "denial" for Allay. Correct? Does he mean no "denials" AFTER we have appealed their decision on Allay?
Need bid to come up to see any kind of run. Increased bids show demand.
If it passes through .0054 with some volume I'll start paying more attention and watch closely.
I am "hopefully" predicting that all products will be lumped together in one approval for all. Since all are based on the same technology, this could be the reason for the LONG delay.
Does anyone know why you still cannot buy this (BIEL) on Ameritrade.
Given your theory has any merit, thus the need for labeling, instructions and restrictions. This is protocal for all drugs!
How about the status on Actipach with the US FDA. We have not recieved any word yet on that. I was once under the assumption (belief) that the FDA was bunching all products together, since they are based on the same technology, and would decide on all at once. But the denial of Allay, shot that theory right out the window. Now my feeling is, Allay was reviewed seperately, because of the sensitive area of usage on the female anatomy - the reproductive system. Special scrutiny (IMO) was needed by the FDA to eliminate any foreseen problems to an area affecting pregnancies and fertilization leading to child birth. Thus my belief, the reason for the meeting with FDA for further information. The Actipatch, being used on other areas of the body such as muscle and joints, is proven safe to areas that are less sensitve than Allay, thus was reviewd seperately and hopefully found to be safer just because of "where" is is placed. Correct package information and restrictions for all products are what I believe to be the "key" to FDA decision and hopefully all that is left before clearing Actipatch and Allay. If efficacy is the holdup, then all bets are off, as more of a delay will occur with more trials possibly required. IMO
I respectfully totally disagree with you. If you don't think that our powerful pharma companies have their connections in Congress and our administration to continually benefit their "business" plan, then you are underestimating "the American way" in corporate America. Even if/when BIEL gets US approval, this delay has sugnificantly destroyed the stock price, which plays right into the hands of a buyout. They ARE BIG PLAYERS in our financial markets with extraordinary capitalization. I am not saying this IS what is happening to BIEL, but to exclude such a theory, would be totally nieve. -- all imo